Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Chronic myeloid leukemia patients treated with tyrosine kinase inhibitors have quality-of-life issues

Chronic myeloid leukemia patients treated with tyrosine kinase inhibitors have quality-of-life issues

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

Discovery of impaired molecular pathway may help treat children with leukemia

Discovery of impaired molecular pathway may help treat children with leukemia

Genetic testing of chronic neutrophilic leukemia reveals presence of new mutation in patients

Genetic testing of chronic neutrophilic leukemia reveals presence of new mutation in patients

Inflection Biosciences signs license agreement with CNIO to develop kinase inhibitors for cancer treatment

Inflection Biosciences signs license agreement with CNIO to develop kinase inhibitors for cancer treatment

BioLineRx starts enrollment in Phase 2 trial of BL-8040 for treatment of AML

BioLineRx starts enrollment in Phase 2 trial of BL-8040 for treatment of AML

Researchers demonstrate how modified citrus pectin works against cancer

Researchers demonstrate how modified citrus pectin works against cancer

Researchers identify a new mechanism that appears to suppress tumor growth

Researchers identify a new mechanism that appears to suppress tumor growth

Researchers identify ways to inhibit function of key protein linked to stem cell-like behavior in CML

Researchers identify ways to inhibit function of key protein linked to stem cell-like behavior in CML

Three easy steps for cancer survivorship

Three easy steps for cancer survivorship

Survival rates increased among patients who received blood stem cell transplants: Study

Survival rates increased among patients who received blood stem cell transplants: Study

DCPrime completes DCP-001 Phase I/IIa study in patients with acute myeloid leukemia

DCPrime completes DCP-001 Phase I/IIa study in patients with acute myeloid leukemia

GATA-3 protein plays an important role in mammalian immune response

GATA-3 protein plays an important role in mammalian immune response

Liposomal anthracycline-based chemotherapy effective for children with leukemia: Study

Liposomal anthracycline-based chemotherapy effective for children with leukemia: Study

Cancer experts to discuss latest developments and implications of cell therapies in oncology

Cancer experts to discuss latest developments and implications of cell therapies in oncology

Caltech biologists show that microRNA-146a protects stem cells during inflammation

Caltech biologists show that microRNA-146a protects stem cells during inflammation

Pfizer halts Phase 3 open-label, two-arm study of lymphoma drug

Pfizer halts Phase 3 open-label, two-arm study of lymphoma drug

New computational method may help track tumor progression, risk of relapse

New computational method may help track tumor progression, risk of relapse

BioLineRx signs ATM sales agency agreement with Stifel

BioLineRx signs ATM sales agency agreement with Stifel

Viewpoints: When a doctor should keep quiet; 2 views of hospital pricing; Stem cell 'snake oil'

Viewpoints: When a doctor should keep quiet; 2 views of hospital pricing; Stem cell 'snake oil'

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.